A novel decision-making tool for first-line treatment selection in metastatic non-small cell lung cancer based on plasma proteome profiling
Petros Christopoulos, View ORCID ProfileMichal Harel, Coren Lahav, Itamar Sela, Nili Dahan, Niels Reinmuth, Ina Koch, Alona Zer, Mor Moskovitz, Adva Levy-Barda, Michal Lotem, Hovav Nechushtan, Rivka Katzenelson, Abed Agbarya, Mahmoud Abu-Amna, Maya Gottfried, Ella Tepper, Christine B. Ambrosone, Ido Wolf, Yanyan Lou, Raya Leibowitz, Adam P. Dicker, David P. Carbone, David Gandara
doi: https://doi.org/10.1101/2022.12.01.22282769
Petros Christopoulos
1Department of Thoracic Oncology, Thoraxklinik at Heidelberg University Hospital and National Center for Tumor Diseases, Heidelberg, 69126, Germany
2Translational Lung Research Center Heidelberg (TLRC-H), member of the German Center for Lung Research (DZL), Heidelberg, 69120, Germany
Michal Harel
3OncoHost LTD, Binyamina, 3057324, Israel
Coren Lahav
3OncoHost LTD, Binyamina, 3057324, Israel
Itamar Sela
3OncoHost LTD, Binyamina, 3057324, Israel
Nili Dahan
3OncoHost LTD, Binyamina, 3057324, Israel
Niels Reinmuth
4Asklepios Kliniken GmbH, Asklepios Fachkliniken Muenchen, Gauting, 82131, Germany
Ina Koch
4Asklepios Kliniken GmbH, Asklepios Fachkliniken Muenchen, Gauting, 82131, Germany
Alona Zer
5Department of Oncology, Rambam Medical Center, Haifa, 3109601, Israel
Mor Moskovitz
6Thoracic Cancer Service, Rabin Medical Center Davidoff Cancer Centre, Beilinson Campus, Petah Tikva, 4941492, Israel
Adva Levy-Barda
7Biobank, Department of pathology, Rabin Medical Center - Belinson campus, Petah Tikva, 4941492, Israel
Michal Lotem
8Center for Melanoma and Cancer Immunotherapy, Hadassah Hebrew University Medical Center, Sharett Institute of Oncology, Jerusalem, 9112001, Israel
Hovav Nechushtan
9Oncology Laboratory, Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, 9112102, Israel
Rivka Katzenelson
10Kaplan Medical Center, Rehovot, 7642002, Israel
Abed Agbarya
11Institute of Oncology, Bnai Zion Medical Center, Haifa, 3339419, Israel
Mahmoud Abu-Amna
12Oncology & Hematology Division, Cancer Center, Emek Medical Center, Afula, 1834111, Israel
Maya Gottfried
13Department of Oncology, Meir Medical Center, Kfar-Saba, 4428164, Israel
Ella Tepper
14Department of Oncology, Assuta Hospital, Tel Aviv, 6971028, Israel
Christine B. Ambrosone
15Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA
16The Roswell Park Comprehensive Cancer Center Data Bank and BioRepository
Ido Wolf
17Division of Oncology, Tel-Aviv Sourasky Medical Center, Tel Aviv, 6423906, Israel
Yanyan Lou
18Division of Hematology and Oncology, Mayo Clinic School of Medicine, Jacksonville, FL 32224, USA
Raya Leibowitz
19Shamir Medical Center, Oncology Institute, Zerifin, 70300, Israel
Adam P. Dicker
20Thomas Jefferson University, Philadelphia, 19107, PA, USA
David P. Carbone
21Comprehensive Cancer Center, The Ohio State University, 460W 12th Ave., Columbus, OH, 43210, USA
David Gandara
22Division of Hematology and Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, CA 95817, USA
Data Availability
Data produced in the present study are available upon reasonable request to the authors
Posted January 31, 2023.
A novel decision-making tool for first-line treatment selection in metastatic non-small cell lung cancer based on plasma proteome profiling
Petros Christopoulos, Michal Harel, Coren Lahav, Itamar Sela, Nili Dahan, Niels Reinmuth, Ina Koch, Alona Zer, Mor Moskovitz, Adva Levy-Barda, Michal Lotem, Hovav Nechushtan, Rivka Katzenelson, Abed Agbarya, Mahmoud Abu-Amna, Maya Gottfried, Ella Tepper, Christine B. Ambrosone, Ido Wolf, Yanyan Lou, Raya Leibowitz, Adam P. Dicker, David P. Carbone, David Gandara
medRxiv 2022.12.01.22282769; doi: https://doi.org/10.1101/2022.12.01.22282769
A novel decision-making tool for first-line treatment selection in metastatic non-small cell lung cancer based on plasma proteome profiling
Petros Christopoulos, Michal Harel, Coren Lahav, Itamar Sela, Nili Dahan, Niels Reinmuth, Ina Koch, Alona Zer, Mor Moskovitz, Adva Levy-Barda, Michal Lotem, Hovav Nechushtan, Rivka Katzenelson, Abed Agbarya, Mahmoud Abu-Amna, Maya Gottfried, Ella Tepper, Christine B. Ambrosone, Ido Wolf, Yanyan Lou, Raya Leibowitz, Adam P. Dicker, David P. Carbone, David Gandara
medRxiv 2022.12.01.22282769; doi: https://doi.org/10.1101/2022.12.01.22282769
Subject Area
Subject Areas
- Addiction Medicine (322)
- Allergy and Immunology (626)
- Anesthesia (162)
- Cardiovascular Medicine (2352)
- Dermatology (206)
- Emergency Medicine (377)
- Epidemiology (11740)
- Forensic Medicine (10)
- Gastroenterology (698)
- Genetic and Genomic Medicine (3712)
- Geriatric Medicine (347)
- Health Economics (632)
- Health Informatics (2383)
- Health Policy (928)
- Hematology (340)
- HIV/AIDS (776)
- Medical Education (364)
- Medical Ethics (104)
- Nephrology (397)
- Neurology (3468)
- Nursing (197)
- Nutrition (521)
- Oncology (1809)
- Ophthalmology (534)
- Orthopedics (218)
- Otolaryngology (286)
- Pain Medicine (232)
- Palliative Medicine (66)
- Pathology (445)
- Pediatrics (1026)
- Primary Care Research (417)
- Public and Global Health (6116)
- Radiology and Imaging (1268)
- Respiratory Medicine (823)
- Rheumatology (379)
- Sports Medicine (320)
- Surgery (398)
- Toxicology (50)
- Transplantation (171)
- Urology (145)